Health Officials Have Done Little to Warn Past Users about Zantac Cancer Risks
Over the last few decades, millions of Americans took the popular medication Zantac for the treatment and prevention of heartburn. Zantac first came into the market in 1983, with massive advertising campaigns promoting the medication as safe and effective. As an over-the-counter (OTC) drug, an estimated 15 million people took Zantac (ranitidine) to relieve heartburn, prevent ulcers, and treat gastroesophageal reflux disease.
However, in 2019 health officials discovered that generic and brand-name versions of ranitidine were contaminated by a chemical known as N-nitrosodimethylamine (NDMA). The U.S. Food & Drug Administration (FDA) classifies NDMA as a likely human carcinogen, a “known environmental contaminant found in water and foods, including meats, dairy products, and vegetables.”
Numerous studies link NDMA exposure to an increased risk of developing cancer, notably liver, kidney, colorectal, and bladder cancer. In fact, a study released by Occupational and Environmental Medicine found that rubber workers exposed to NDMA in factories had an increase in developing esophageal, oral cavity, and pharynx cancer.
According to the FDA, Zantac’s active ingredient may convert into NDMA when stored at higher than room temperatures, exposing consumers to unacceptably high levels of the carcinogen. On April 1, 2020, the FDA issued a request for the removal of all Zantac and ranitidine products from the market due to the risk of NDMA exposure.
However, according to a recent report, health officials have not done a lot to alert former Zantac users about the recall and the cancer risks from using ranitidine. In fact, legal services and lawyers largely took it upon themselves to get the word out to past users.
Though stores pulled Zantac products from their shelves and the FDA issued their recall of all ranitidine products, former users were left to find out through TV commercials that their Zantac medication could be behind their cancer diagnoses. In the wake of the Zantac recall, lawyers across the country released digital marketing campaigns alerting the public about the recall, informing both past and present users of the medication of the NDMA exposure risk.
Many of the consumers filling Zantac cancer lawsuits say it was through a TV commercial or a Facebook advertisement that they found out about the Zantac recall and NDMA contamination. A growing number of Zantac lawsuits are now being filed in courts nationwide, each raising similar claims that NDMA in Zantac caused their stomach cancer, testicular cancer, and breast cancer diagnoses, among others.
With the limited media coverage, many individuals remain unaware that their prior use of Zantac may have caused their cancer diagnoses. Reports indicate lawyers are currently investigating tens of thousands of Zantac cancer cases across the U.S.
Did You Take Zantac and Were Diagnosed with Cancer?
If you took Zantac and developed cancer, you may be eligible to file a claim against Zantac manufacturers for your injuries. By failing to ensure their product was safe, Zantac manufacturers put your life and livelihood on the line. Their negligence should be held accountable, not only to ensure justice for you but to protect future consumers.
If you believe your cancer diagnosis is linked to your use of Zantac or ranitidine medications, reach out to the attorneys at AVA Law Group today. By filling a claim against Zantac manufacturers, we can recover compensation for your Zantac injuries, like medical monitoring, medical bills, loss of wages, and pain and suffering.
When you partner with the team AVA Law Group, you are instantly connected to top-notch personal injury lawyers with the experience and skills necessary to care for your case needs. We fight aggressively for your right to compensation and take the burden of filing a claim off your plate; leave your worries to us!
To learn more and receive your free, no-obligation case evaluation, call us today at 1.800.777.4141.